Search tips
Search criteria 


Logo of ijpsychHomeCurrent issueInstructionsSubmit article
Indian J Psychiatry. 2004 Jul-Sep; 46(3): 213–220.
PMCID: PMC2951646

Pharmacotherapy of Sexual Dysfunctions : Current Status


The sexual dysfunctions are one of the most prevalent conditions. Sexual dysfunctions can have profound effect on the psychological well-being of an individual and the psychosexual relationship of a couple. Management of the sexual dysfunction should be preceded by an accurate diagnosis reached after a complete medical and sexual history and physical examination. Current focus of researchers has been on understanding the pathophysiology of erectile dysfunction, premature ejaculation and other sexual dysfunctions that can help in developing newer pharmacological cures for these conditions.

Recently, a number of clinical trials have studied the potential effectiveness of the phosphodiesterase (PDE)-5 inhibitor sildenafil in the treatment of Erectile Dysfunction (ED) and Premature Ejaculation (PME). The introduction of PDE-5 inhibitors like sildenafil, vardenafil and tadalafil has revolutionized the treatment of sexual dysfunctions.

This review focuses on the recent pharmacological advances in the treatment of common sexual dysfunctions like ED and PME with special focus on the role of PDE-5 inhibitors. Also discussed is the pharmacological treatment of other less prevalent and recognized disorders like female sexual dysfunction, drug induced sexual dysfunction etc.

Keywords: Erectile dysfunction, premature ejaculation, sildenafil, PDE-5 inhibitors, sexual dysfunction

Full Text

The Full Text of this article is available as a PDF (429K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Abdel-Hamid Ibrahim A. Phosphodiesterase 5 inhibitors in rapid ejaculation: potential use and possible mechanisms of action. Drugs. 2004;64(1):13–26. [PubMed]
  • Abdel-Hamid IA, El Naggar EA, El Gilany AH. Assessment of as needed use of pharmacotherapy and the pause-squeeze technique in premature ejaculation. Int J Impot Res. 2001 Feb;13(1):41–45. [PubMed]
  • Althof SE, Seftel AD. The evaluation and management of erectile dysfunction. Psychiatr Clin North Am. 1995 Mar;18(1):171–192. [PubMed]
  • Atan A, Başar MM, Aydoğanli L. Comparison of the efficacy of fluoxetine alone vs. fluoxetine plus local lidocaine ointment in the treatment of premature ejaculation. Arch Esp Urol. 2000 Nov;53(9):856–858. [PubMed]
  • Aversa A, Pili M, Fabbri A, Spera E, Spera G. Erectile dysfunction: expectations beyond phosphodiesterase type 5 inhibition. J Endocrinol Invest. 2004 Feb;27(2):192–206. [PubMed]
  • Balachandra K. Re: Treatment of premature ejaculation with paroxetine hydrochloride as needed: 2 single-blind placebo controlled crossover studies. J Urol. 2001 Dec;166(6):2325–2325. [PubMed]
  • Bella Anthony J, Brock Gerald B. Intracavernous pharmacotherapy for erectile dysfunction. Endocrine. 2004 Mar-Apr;23(2-3):149–155. [PubMed]
  • Brindley GS. Cavernosal alpha-blockade: a new technique for investigating and treating erectile impotence. Br J Psychiatry. 1983 Oct;143:332–337. [PubMed]
  • Burger M, Sikka SC, Bivalacqua TJ, Lamb DJ, Hellstrom WJ. The effect of sildenafil on human sperm motion and function from normal and infertile men. Int J Impot Res. 2000 Aug;12(4):229–234. [PubMed]
  • Burnett AL. Erectile dysfunction: a practical approach for primary care. Geriatrics. 1998 Feb;53(2):34–48. [PubMed]
  • Caruso Salvatore, Agnello Carmela, Intelisano Giorgia, Farina Marco, Di Mari Lucia, Cianci Antonio. Placebo-controlled study on efficacy and safety of daily apomorphine SL intake in premenopausal women affected by hypoactive sexual desire disorder and sexual arousal disorder. Urology. 2004 May;63(5):955–959. [PubMed]
  • Cavallini G. Minoxidil versus nitroglycerine: a prospective, double-blind, controlled trial in transcutaneous therapy for organic impotence. Int J Impot Res. 1994 Dec;6(4):205–212. [PubMed]
  • Chen J, Mabjeesh NJ, Greenstein A, Nadu A, Matzkin H. Clinical efficacy of sildenafil in patients on chronic dialysis. J Urol. 2001 Mar;165(3):819–821. [PubMed]
  • Chen Juza, Mabjeesh Nicola J, Matzkin Haim, Greenstein Alexander. Efficacy of sildenafil as adjuvant therapy to selective serotonin reuptake inhibitor in alleviating premature ejaculation. Urology. 2003 Jan;61(1):197–200. [PubMed]
  • Mills TM, Chitaley K, Wingard CJ, Lewis RW, Webb RC. Effect of Rho-kinase inhibition on vasoconstriction in the penile circulation. J Appl Physiol (1985) 2001 Sep;91(3):1269–1273. [PubMed]
  • Choi HK, Jung GW, Moon KH, Xin ZC, Choi YD, Lee WH, Rha KH, Choi YJ, Kim DK. Clinical study of SS-cream in patients with lifelong premature ejaculation. Urology. 2000 Feb;55(2):257–261. [PubMed]
  • Choi HK, Xin ZC, Choi YD, Lee WH, Mah SY, Kim DK. Safety and efficacy study with various doses of SS-cream in patients with premature ejaculation in a double-blind, randomized, placebo controlled clinical study. Int J Impot Res. 1999 Oct;11(5):261–264. [PubMed]
  • Conti CR, Pepine CJ, Sweeney M. Efficacy and safety of sildenafil citrate in the treatment of erectile dysfunction in patients with ischemic heart disease. Am J Cardiol. 1999 Mar 4;83(5A):29C–34C. [PubMed]
  • Costa P. Multidimensional nature of apomorphine SL (Ixense) therapy. Int J Impot Res. 2003 Apr;15 (Suppl 2):S13–S15. [PubMed]
  • Crowe Susan M, Streetman Daniel S. Vardenafil treatment for erectile dysfunction. Ann Pharmacother. 2004 Jan;38(1):77–85. [PubMed]
  • Cuadra DL, Chan PJ, Patton WC, Stewart SC, King A. Type 5 phosphodiesterase regulation of human sperm motility. Am J Obstet Gynecol. 2000 May;182(5):1013–1015. [PubMed]
  • Dinsmore WW, Alderdice DK. Vasoactive intestinal polypeptide and phentolamine mesylate administered by autoinjector in the treatment of patients with erectile dysfunction resistant to other intracavernosal agents. Br J Urol. 1998 Mar;81(3):437–440. [PubMed]
  • Dula E, Keating W, Siami PF, Edmonds A, O'neil J, Buttler S. Efficacy and safety of fixed-dose and dose-optimization regimens of sublingual apomorphine versus placebo in men with erectile dysfunction. The Apomorphine Study Group. Urology. 2000 Jul;56(1):130–135. [PubMed]
  • Enzlin P, Vanderschueren D, Bonte L, Vanderborght W, Declercq G, Demyttenaere K. Trazodone: a double-blind, placebo-controlled, randomized study of its effects in patients with erectile dysfunction without major organic findings. Int J Impot Res. 2000 Aug;12(4):223–228. [PubMed]
  • Ernst E, Pittler MH. Yohimbine for erectile dysfunction: a systematic review and meta-analysis of randomized clinical trials. J Urol. 1998 Feb;159(2):433–436. [PubMed]
  • Fink HA, MacDonald R, Rutks IR, Wilt TJ. Trazodone for erectile dysfunction: a systematic review and meta-analysis. BJU Int. 2003 Sep;92(4):441–446. [PubMed]
  • Goldstein I, Carson C, Rosen R, Islam A. Vasomax for the treatment of male erectile dysfunction. World J Urol. 2001 Feb;19(1):51–56. [PubMed]
  • Govier FE, McClure RD, Weissman RM, Gibbons RP, Pritchett TR, Kramer-Levien D. Experience with triple-drug therapy in a pharmacological erection program. J Urol. 1993 Dec;150(6):1822–1824. [PubMed]
  • Herrmann HC, Chang G, Klugherz BD, Mahoney PD. Hemodynamic effects of sildenafil in men with severe coronary artery disease. N Engl J Med. 2000 Jun 1;342(22):1622–1626. [PubMed]
  • Hussain IF, Brady CM, Swinn MJ, Mathias CJ, Fowler CJ. Treatment of erectile dysfunction with sildenafil citrate (Viagra) in parkinsonism due to Parkinson's disease or multiple system atrophy with observations on orthostatic hypotension. J Neurol Neurosurg Psychiatry. 2001 Sep;71(3):371–374. [PMC free article] [PubMed]
  • Jackson G, Benjamin N, Jackson N, Allen MJ. Effects of sildenafil citrate on human hemodynamics. Am J Cardiol. 1999 Mar 4;83(5A):13C–20C. [PubMed]
  • Keating Gillian M, Scott Lesley J. Spotlight on vardenafil in erectile dysfunction. Drugs Aging. 2004;21(2):135–140. [PubMed]
  • Kloner RA, Jarow JP. Erectile dysfunction and sildenafil citrate and cardiologists. Am J Cardiol. 1999 Feb 15;83(4):576–A7. [PubMed]
  • Kloner RA, Brown M, Prisant LM, Collins M. Effect of sildenafil in patients with erectile dysfunction taking antihypertensive therapy. Sildenafil Study Group. Am J Hypertens. 2001 Jan;14(1):70–73. [PubMed]
  • Kloner Robert A, Mitchell Malcolm, Emmick Jeffrey T. Cardiovascular effects of tadalafil. Am J Cardiol. 2003 Nov 6;92(9A):37M–46M. [PubMed]
  • Krane RJ, Goldstein I, Saenz de Tejada I. Impotence. N Engl J Med. 1989 Dec 14;321(24):1648–1659. [PubMed]
  • Krege S, Goepel M, Sperling H, Michel MC. Affinity of trazodone for human penile alpha1- andalpha2-adrenoceptors. BJU Int. 2000 May;85(7):959–961. [PubMed]
  • Kriegsfeld LJ, Demas GE, Huang PL, Burnett AL, Nelson RJ. Ejaculatory abnormalities in mice lacking the gene for endothelial nitric oxide synthase (eNOS-/-). Physiol Behav. 1999 Oct;67(4):561–566. [PubMed]
  • Labbate Lawrence A, Croft Harry A, Oleshansky Marvin A. Antidepressant-related erectile dysfunction: management via avoidance, switching antidepressants, antidotes, and adaptation. J Clin Psychiatry. 2003;64 (Suppl 10):11–19. [PubMed]
  • Levine LA. Diagnosis and treatment of erectile dysfunction. Am J Med. 2000 Dec 18;109 (Suppl 9A):3S–30S. [PubMed]
  • Linet OI, Ogrinc FG. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. The Alprostadil Study Group. N Engl J Med. 1996 Apr 4;334(14):873–877. [PubMed]
  • Llisterri JL, Lozano Vidal JV, Aznar Vicente J, Argaya Roca M, Pol Bravo C, Sanchez Zamorano MA, Ferrario CM. Sexual dysfunction in hypertensive patients treated with losartan. Am J Med Sci. 2001 May;321(5):336–341. [PubMed]
  • Ludovico GM, Corvasce A, Pagliarulo G, Cirillo-Marucco E, Marano A, Pagliarulo A. Paroxetine in the treatment of premature ejaculation. Br J Urol. 1996 Jun;77(6):881–882. [PubMed]
  • McMahon CG, Touma K. Treatment of premature ejaculation with paroxetine hydrochloride. Int J Impot Res. 1999 Oct;11(5):241–246. [PubMed]
  • Mann K, Klingler T, Noe S, Röschke J, Müller S, Benkert O. Effects of yohimbine on sexual experiences and nocturnal penile tumescence and rigidity in erectile dysfunction. Arch Sex Behav. 1996 Feb;25(1):1–16. [PubMed]
  • Modell JG, May RS, Katholi CR. Effect of bupropion-SR on orgasmic dysfunction in nondepressed subjects: a pilot study. J Sex Marital Ther. 2000 Jul-Sep;26(3):231–240. [PubMed]
  • Monsma FJ, Jr, Shen Y, Ward RP, Hamblin MW, Sibley DR. Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs. Mol Pharmacol. 1993 Mar;43(3):320–327. [PubMed]
  • Montague DK, Barada JH, Belker AM, Levine LA, Nadig PW, Roehrborn CG, Sharlip ID, Bennett AH. Clinical guidelines panel on erectile dysfunction: summary report on the treatment of organic erectile dysfunction. The American Urological Association. J Urol. 1996 Dec;156(6):2007–2011. [PubMed]
  • Montorsi Francesco, Briganti Alberto, Salonia Andrea, Rigatti Patrizio, Burnett Arthur L. Current and future strategies for preventing and managing erectile dysfunction following radical prostatectomy. Eur Urol. 2004 Feb;45(2):123–133. [PubMed]
  • Morales A, Gingell C, Collins M, Wicker PA, Osterloh IH. Clinical safety of oral sildenafil citrate (VIAGRA) in the treatment of erectile dysfunction. Int J Impot Res. 1998 Jun;10(2):69–74. [PubMed]
  • Moreira SG, Jr, Brannigan RE, Spitz A, Orejuela FJ, Lipshultz LI, Kim ED. Side-effect profile of sildenafil citrate (Viagra) in clinical practice. Urology. 2000 Sep 1;56(3):474–476. [PubMed]
  • Muirhead GJ, Wulff MB, Fielding A, Kleinermans D, Buss N. Pharmacokinetic interactions between sildenafil and saquinavir/ritonavir. Br J Clin Pharmacol. 2000 Aug;50(2):99–107. [PMC free article] [PubMed]
  • Mulhall JP, Daller M, Traish AM, Gupta S, Park K, Salimpour P, Payton TR, Krane RJ, Goldstein I. Intracavernosal forskolin: role in management of vasculogenic impotence resistant to standard 3-agent pharmacotherapy. J Urol. 1997 Nov;158(5):1752–1759. [PubMed]
  • Murat Başar M, Atan A, Yildiz M, Baykam M, Aydogănli L. Comparison of sertraline to fluoxetine with regard to their efficacy and side effects in the treatment of premature ejaculation. Arch Esp Urol. 1999 Nov;52(9):1008–1011. [PubMed]
  • Nehra A, Colreavy F, Khandheria BK, Chandrasekaran K. Sildenafil citrate, a selective phosphodiesterase type 5 inhibitor: urologic and cardiovascular implications. World J Urol. 2001 Feb;19(1):40–45. [PubMed]
  • Padma-Nathan Harin. Efficacy and tolerability of tadalafil, a novel phosphodiesterase 5 inhibitor, in treatment of erectile dysfunction. Am J Cardiol. 2003 Nov 6;92(9A):19M–25M. [PubMed]
  • Padma-Nathan H, Goldstein I, Klimberg I, Coogan C, Auerbach S, Lammers P. Long-term safety and efficacy of oral phentolamine mesylate (Vasomax) in men with mild to moderate erectile dysfunction. Int J Impot Res. 2002 Aug;14(4):266–270. [PubMed]
  • Padma-Nathan H, Steers WD, Wicker PA. Efficacy and safety of oral sildenafil in the treatment of erectile dysfunction: a double-blind, placebo-controlled study of 329 patients. Sildenafil Study Group. Int J Clin Pract. 1998 Sep;52(6):375–379. [PubMed]
  • Piletz JE, Segraves KB, Feng YZ, Maguire E, Dunger B, Halaris A. Plasma MHPG response to yohimbine treatment in women with hypoactive sexual desire. J Sex Marital Ther. 1998 Jan-Mar;24(1):43–54. [PubMed]
  • Porst H. The rationale for prostaglandin E1 in erectile failure: a survey of worldwide experience. J Urol. 1996 Mar;155(3):802–815. [PubMed]
  • Porst H, Rosen R, Padma-Nathan H, Goldstein I, Giuliano F, Ulbrich E, Bandel T. The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial. Int J Impot Res. 2001 Aug;13(4):192–199. [PubMed]
  • Purvis K, Egdetveit I, Christiansen E. Intracavernosal therapy for erectile failure--impact of treatment and reasons for drop-out and dissatisfaction. Int J Impot Res. 1999 Oct;11(5):287–299. [PubMed]
  • Rendell MS, Rajfer J, Wicker PA, Smith MD. Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study Group. JAMA. 1999 Feb 3;281(5):421–426. [PubMed]
  • Rosen Raymond C, Marin Humberto. Prevalence of antidepressant-associated erectile dysfunction. J Clin Psychiatry. 2003;64 (Suppl 10):5–10. [PubMed]
  • Sadovsky R, Miller T, Moskowitz M, Hackett G. Three-year update of sildenafil citrate (Viagra) efficacy and safety. Int J Clin Pract. 2001 Mar;55(2):115–128. [PubMed]
  • Salonia Andrea, Maga Tommaso, Colombo Renzo, Scattoni Vinenzo, Briganti Alberto, Cestari Andrea, Guazzoni Giorgio, Rigatti Patrizio, Montorsi Francesco. A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation. J Urol. 2002 Dec;168(6):2486–2489. [PubMed]
  • Sathe RS, Komisaruk BR, Ladas AK, Godbole SV. Naltrexone-induced augmentation of sexual response in men. Arch Med Res. 2001 May-Jun;32(3):221–226. [PubMed]
  • Seftel Allen D, Mohammed Mamdouh Ab, Althof Stanley E. Erectile dysfunction: etiology, evaluation, and treatment options. Med Clin North Am. 2004 Mar;88(2):387–xi. [PubMed]
  • Segraves RT, Croft H, Kavoussi R, Ascher JA, Batey SR, Foster VJ, Bolden-Watson C, Metz A. Bupropion sustained release (SR) for the treatment of hypoactive sexual desire disorder (HSDD) in nondepressed women. J Sex Marital Ther. 2001 May-Jun;27(3):303–316. [PubMed]
  • Seidman SN, Roose SP, Menza MA, Shabsigh R, Rosen RC. Treatment of erectile dysfunction in men with depressive symptoms: results of a placebo-controlled trial with sildenafil citrate. Am J Psychiatry. 2001 Oct;158(10):1623–1630. [PubMed]
  • Sommer Frank, Engelmann Udo. Future options for combination therapy in the management of erectile dysfunction in older men. Drugs Aging. 2004;21(9):555–564. [PubMed]
  • Traish A, Gupta S, Gallant C, Huang YH, Goldstein I. Phentolamine mesylate relaxes penile corpus cavernosum tissue by adrenergic and non-adrenergic mechanisms. Int J Impot Res. 1998 Dec;10(4):215–223. [PubMed]
  • van Ahlen H, Piechota HJ, Kias HJ, Brennemann W, Klingmüller D. Opiate antagonists in erectile dysfunction: a possible new treatment option? Results of a pilot study with naltrexone. Eur Urol. 1995;28(3):246–250. [PubMed]
  • Virag R. Intracavernous injection of papaverine for erectile failure. Lancet. 1982 Oct 23;2(8304):938–938. [PubMed]
  • Vogt HJ, Brandl P, Kockott G, Schmitz JR, Wiegand MH, Schadrack J, Gierend M. Double-blind, placebo-controlled safety and efficacy trial with yohimbine hydrochloride in the treatment of nonorganic erectile dysfunction. Int J Impot Res. 1997 Sep;9(3):155–161. [PubMed]
  • Waldinger MD, Zwinderman AH, Schweitzer DH, Olivier B. Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: a systematic review and meta-analysis. Int J Impot Res. 2004 Aug;16(4):369–381. [PubMed]
  • Warnock JK, Bundren JC, Morris DW. Female hypoactive sexual disorder: case studies of physiologic androgen replacement. J Sex Marital Ther. 1999 Jul-Sep;25(3):175–182. [PubMed]
  • Webb DJ, Muirhead GJ, Wulff M, Sutton JA, Levi R, Dinsmore WW. Sildenafil citrate potentiates the hypotensive effects of nitric oxide donor drugs in male patients with stable angina. J Am Coll Cardiol. 2000 Jul;36(1):25–31. [PubMed]
  • Wessells H, Fuciarelli K, Hansen J, Hadley ME, Hruby VJ, Dorr R, Levine N. Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: double-blind, placebo controlled crossover study. J Urol. 1998 Aug;160(2):389–393. [PubMed]
  • Yap Ronald L, McVary Kevin T. Topical agents and erectile dysfunction: is there a place? Curr Urol Rep. 2002 Dec;3(6):471–476. [PubMed]
  • Zagaja GP, Mhoon DA, Aikens JE, Brendler CB. Sildenafil in the treatment of erectile dysfunction after radical prostatectomy. Urology. 2000 Oct 1;56(4):631–634. [PubMed]
  • Zesiewicz TA, Helal M, Hauser RA. Sildenafil citrate (Viagra) for the treatment of erectile dysfunction in men with Parkinson's disease. Mov Disord. 2000 Mar;15(2):305–308. [PubMed]

Articles from Indian Journal of Psychiatry are provided here courtesy of Wolters Kluwer -- Medknow Publications